{"id":54377,"date":"2023-03-01T14:04:36","date_gmt":"2023-03-01T13:04:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/"},"modified":"2023-03-01T14:04:36","modified_gmt":"2023-03-01T13:04:36","slug":"edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/","title":{"rendered":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023"},"content":{"rendered":"
\n

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET.\n<\/p>\n

<\/a><\/p>\n

\nThe presentation will be webcast live; a link for the webcast can be found on the Edgewise events page<\/a> and will be accessible for replay following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.\n<\/p>\n

\nAbout Edgewise Therapeutics<\/b>\n<\/p>\n

\nEdgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe, rare neuromuscular and cardiac disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle-focused drug discovery platform. Edgewise\u2019s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue. The Company\u2019s lead candidate, EDG-5506, an investigational orally administered small molecule myosin modulator designed to protect injury-susceptible fast skeletal muscle fibers in dystrophinopathies, is advancing in multiple clinical trials in individuals with Duchenne, Becker and Limb Girdle 2i muscular dystrophies, and McArdle\u2019s disease. The Company is also advancing EDG-7500, a novel sarcomere modulator for hypertrophic cardiomyopathy, into IND-enabling preclinical development. To learn more, go to: www.edgewisetx.com<\/a> or follow us on LinkedIn<\/a>, Twitter<\/a> and Facebook<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors & Media<\/b>
Michael Carruthers
\n
Chief Financial Officer
\n
ir@edgewisetx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET. The presentation will be webcast … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-54377","format-standard","category-industry"],"yoast_head":"\nEdgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET. The presentation will be webcast ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-01T13:04:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023\",\"datePublished\":\"2023-03-01T13:04:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/\"},\"wordCount\":303,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005018\\\/en\\\/1382019\\\/21\\\/Edgewise-Logo_FINAL.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/\",\"name\":\"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005018\\\/en\\\/1382019\\\/21\\\/Edgewise-Logo_FINAL.jpg\",\"datePublished\":\"2023-03-01T13:04:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005018\\\/en\\\/1382019\\\/21\\\/Edgewise-Logo_FINAL.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230301005018\\\/en\\\/1382019\\\/21\\\/Edgewise-Logo_FINAL.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/","og_locale":"en_US","og_type":"article","og_title":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend","og_description":"BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023, at 9:10 am ET. The presentation will be webcast ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-01T13:04:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023","datePublished":"2023-03-01T13:04:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/"},"wordCount":303,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/","url":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/","name":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg","datePublished":"2023-03-01T13:04:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230301005018\/en\/1382019\/21\/Edgewise-Logo_FINAL.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/edgewise-therapeutics-to-present-at-the-cowen-43rd-annual-health-care-conference-on-march-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54377"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54377\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}